Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

UCB:BB

68.3500 EUR 1.2600 1.81%

As of 11:35:30 ET on 02/27/2015.

Snapshot for UCB SA (UCB)

Open: 68.5800 Day's Range: 65.3800 - 68.8000 Volume: 714,767
Previous Close: 69.6100 52wk Range: 54.5300 - 75.6200 1-Yr Rtn: +19.60%

Stock Chart for UCB

No chart data available.
  • UCB:BB 68.3500
  • 1D
  • 1M
  • 1Y
69.6100
Interactive UCB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UCB

Current P/E Ratio (ttm) 43.0853
Estimated P/E(12/2015) 33.2927
Relative P/E vs. BEL20 1.1315
Earnings Per Share (EUR) (ttm) 1.5864
Est. EPS (EUR) (12/2015) 2.0530
Est. PEG Ratio 1.3534
Market Cap (M EUR) 13,294.46
Shares Outstanding (M) 194.51
30 Day Average Volume 326,733
Price/Book (mrq) 2.7639
Price/Sale (ttm) 4.4545
Dividend Indicated Gross Yield 1.55%
Cash Dividend (EUR) 0.7950
Dividend Ex-Date
5 Year Dividend Growth 2.48%
Next Earnings Announcement 07/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UCB

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for UCB

UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders and inflammatory diseases. UCB operates worldwide.

Jean-Christophe TellierChief Executive OfficerBharat TewarieChief Marketing Ofcr
Detlef ThielgenExec VP/CFOIsmail KolaExec VP/Pres:Newmedicines
More Company Profile & Key Executives for UCB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil